| Pharmaceutical active ingredients: |
| Ethinyl EstradiolNorethindrone Acetate |
| Available forms, composition and doses of Anovlar: |
| N / A |
| Anovlar medical category: |
| Human:Oral contraceptives |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| G03AA05 - Norethisterone and estrogenG03AB04 - Norethisterone and estrogenG03CA01 - Ethinylestradiol |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Bayer Schering Pharma |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Synphasic 28 | Ethinyl Estradiol; Norethindrone | Pfizer; Syntex |
| Triella | Ethinyl Estradiol; Norethindrone | Janssen; Codepharma Laboratoire |
| Tri-Norinyl | Ethinyl Estradiol; Norethindrone | Pfizer; Watson Pharmaceuticals |
| TriNovum | Ethinyl Estradiol; Norethindrone | Janssen; Edward Keller |
| TriNovum ED | Ethinyl Estradiol; Norethindrone | Janssen; Ortho McNeil Pharmaceuticals |
| Controvlar | Ethinyl Estradiol; Norethindrone Acetate | Bayer Schering Pharma |
| Econ | Ethinyl Estradiol; Norethindrone Acetate | Orion Pharma |
| Estro-Primolut | Ethinyl Estradiol; Norethindrone Acetate | Bayer Schering Pharma |
| Estrostep | Ethinyl Estradiol; Norethindrone Acetate | Warner Chilcott |
| Estrostep 21 | Ethinyl Estradiol; Norethindrone Acetate | Warner Chilcott |